Other {{label}}

Pediatric Powered Wheelchair Standing Devices: An Exploratory Study

Please note: All trial information reflects the latest data available from the sponsor on ClinicalTrials.gov and other public databases. However, these sources may occasionally be outdated or inaccurate. For the most current information, we recommend contacting the trial sponsor or sites directly.

Overview

{{trial.Sponsor}} {{trial.Sponsor}}
{{route.Name}}
{{route.Name}}
Approved by FDA
Approved outside USA
Is a supplement

Details

Enrollment Criteria

{{m.Name}}
{{trial.ExternalId}} (First Published: {{trial.FirstPublishedDate|date}} on {{trial.SourceName}})
For children who use a power wheelchair, a powered wheelchair standing device (PWSD) may be considered for daily use. A PWSD allows a child to electronically move between sitting and standing and can be driven in either position. Existing published PWSD research in pediatrics is limited to boys with Duchenne muscular dystrophy (DMD).(1, 2) While these studies provide some insights into PWSD use in boys with DMD, they do not reflect PWSD use in children with other conditions. The purpose of this exploratory study is to determine the feasibility of a research protocol exploring use of a PWSD in children who have neurodevelopmental conditions other than DMD.

Inclusion Criteria:
1. Is 5-17 years of age. NOTE: Participants must be under 18 for the duration of the
study.
2. Diagnosed with a neurodevelopmental condition resulting in an inability to
functionally ambulate.
3. Can safely assume and maintain a supported standing position
4. Has sufficient upper extremity and function to safely use a PWSD
5. Can communicate pain or discomfort through verbalization, vocalization, use of
augmented communication, etc.
6. Can safely use the PWSD in areas of their home
7. Has at least one parent/caregiver who is able to converse in English and actively
participate in a device-use education provided in English
8. The PerMobil PWSD can be set up to meet the child's specific needs
9. Medical Clearance to trial the PWSD
10. Participants must reside in Michigan
Exclusion Criteria:
1. Has a diagnosis of Duchenne muscular dystrophy.
2. Any reason that it would not be safe for the child to use a PWSD

Locations
{{countryGroup}}
{{regionGroup}}
{{location.Facility}}
{{location.City !== '' ? location.City + ',' : ''}} {{location.RegionAbbreviation}} {{location.PostalCode}} {{location.Country}}
{{location.Facility !== '' ? location.Facility + ',' : ''}} {{location.City !== '' ? location.City + ',' : ''}} {{location.RegionAbbreviation}} {{location.PostalCode}} {{location.Country}}
Location Contact: {{location.Contact.Name}} {{location.Contact.Name}} Phone: {{location.Contact.Phone}}
Join the ALS Research Collaborative (ARC) Study Today!
Ready to make a difference in ALS research?
Join the ARC Study! Whether you're living with ALS or an asymptomatic gene carrier, your participation can help inform ALS research and lead to new treatments.
ALS Research Collaborative
Thank You to Our Sponsors
Mitsubishi Tanabe Pharma